Li Xiaofeng, Yang Wanyue, Dai Chunlan, Qiu Ziyang, Luan Xin, Zhang Xuemei, Zhang Lijun
School of Pharmacy, Fudan University, Shanghai, 200120, China.
Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
J Ethnopharmacol. 2025 Jan 31;340:119222. doi: 10.1016/j.jep.2024.119222. Epub 2024 Dec 6.
Quan-du-zhong capsule (QDZ), derived from the whole plant extract of Eucommiaulmoides Oliv., is a traditional Chinese herbal medicine used in treating vascular-related diseases, including hypertension and osteoporosis. Despite its established uses, its pro-angiogenic effects and underlying mechanisms require further investigation.
This study aims to investigate the pro-angiogenic effects of QDZ and explore the underlying mechanisms.
The chemical compositions of QDZ, including its absorbed prototypes in rats, were analyzed using UHPLC-Q Exactive-Orbitrap-MS. The pro-angiogenic activities of QDZ were evaluated in human umbilical vein endothelial cells (HUVECs) through various assays, including CCK-8, migration, scratch, tubule formation, and 3D sprouting assays. Additionally, the pro-angiogenic effects of QDZ were further assessed invivo through the matrigel plug assay and a hindlimb ischemia-reperfusion model, with three-dimensional blood flow visualized via micro-CT. A comprehensive approach involving network pharmacology, molecular docking, transcriptomics, and proteomics was utilized to explore the pro-angiogenic mechanism of QDZ, with validation by Western blot analysis.
QDZ significantly promoted the proliferation, migration, and tubule formation of HUVECs. The matrigel plug assay further confirmed its pro-angiogenic potential. Invivo, QDZ-treated mice displayed enhanced vascular distribution and faster blood flow recovery post-ischemia-reperfusion. Chemical analysis identified 49 compounds in QDZ, with 16 absorbed prototypes detected in rat plasma. Mechanistic investigations through network pharmacology, transcriptomics, and proteomics suggested that QDZ's pro-angiogenic effects were mediated through the VEGFA/PI3K-Akt signaling pathway, with increased phosphorylation of angiogenesis-related proteins such as PI3K, Akt, FAK, and Src.
This study demonstrates that QDZ promotes angiogenesis via activating the VEGFA and its downstream PI3K-Akt signaling pathway, shedding light on the mechanisms that underpin its traditional medicinal use in vascular health.
全杜仲胶囊(QDZ)源自杜仲的全株提取物,是一种用于治疗血管相关疾病(包括高血压和骨质疏松症)的传统中草药。尽管其用途已得到确立,但其促血管生成作用及潜在机制仍需进一步研究。
本研究旨在探讨全杜仲胶囊(QDZ)的促血管生成作用并探索其潜在机制。
采用超高效液相色谱-四极杆-轨道阱质谱联用仪(UHPLC-Q Exactive-Orbitrap-MS)分析全杜仲胶囊(QDZ)的化学成分,包括其在大鼠体内的吸收原型。通过多种实验,包括CCK-8、迁移、划痕、小管形成和三维芽生实验,评估全杜仲胶囊(QDZ)在人脐静脉内皮细胞(HUVECs)中的促血管生成活性。此外,通过基质胶栓塞实验和后肢缺血再灌注模型在体内进一步评估全杜仲胶囊(QDZ)的促血管生成作用,通过微型计算机断层扫描(micro-CT)可视化三维血流。采用网络药理学、分子对接、转录组学和蛋白质组学的综合方法探索全杜仲胶囊(QDZ)的促血管生成机制,并通过蛋白质免疫印迹分析进行验证。
全杜仲胶囊(QDZ)显著促进人脐静脉内皮细胞(HUVECs)的增殖、迁移和小管形成。基质胶栓塞实验进一步证实了其促血管生成潜力。在体内,接受全杜仲胶囊(QDZ)治疗的小鼠在缺血再灌注后显示出增强的血管分布和更快的血流恢复。化学分析鉴定出全杜仲胶囊(QDZ)中的49种化合物,在大鼠血浆中检测到16种吸收原型。通过网络药理学、转录组学和蛋白质组学进行的机制研究表明,全杜仲胶囊(QDZ)的促血管生成作用是通过血管内皮生长因子A(VEGFA)/磷脂酰肌醇-3-激酶-蛋白激酶B(PI3K-Akt)信号通路介导的,血管生成相关蛋白如PI3K、Akt、黏着斑激酶(FAK)和Src的磷酸化增加。
本研究表明,全杜仲胶囊(QDZ)通过激活血管内皮生长因子A(VEGFA)及其下游的PI3K-Akt信号通路促进血管生成,揭示了其在血管健康方面传统药用的潜在机制。